nodes	percent_of_prediction	percent_of_DWPC	metapath
Pancuronium—CHRND—cardiovascular system—attention deficit hyperactivity disorder	0.0173	0.0968	CbGeAlD
Pancuronium—CHRNA2—forebrain—attention deficit hyperactivity disorder	0.0142	0.0793	CbGeAlD
Pancuronium—CHRNB1—midbrain—attention deficit hyperactivity disorder	0.00872	0.0487	CbGeAlD
Pancuronium—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00847	0.0473	CbGeAlD
Pancuronium—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.00832	0.0465	CbGeAlD
Pancuronium—CHRNA2—nervous system—attention deficit hyperactivity disorder	0.00771	0.043	CbGeAlD
Pancuronium—CHRNA2—central nervous system—attention deficit hyperactivity disorder	0.00742	0.0414	CbGeAlD
Pancuronium—CHRNA2—cerebellum—attention deficit hyperactivity disorder	0.00725	0.0405	CbGeAlD
Pancuronium—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00716	0.04	CbGeAlD
Pancuronium—CHRNA1—brain—attention deficit hyperactivity disorder	0.0071	0.0397	CbGeAlD
Pancuronium—CHRM3—forebrain—attention deficit hyperactivity disorder	0.0069	0.0385	CbGeAlD
Pancuronium—CHRNB1—cerebellum—attention deficit hyperactivity disorder	0.00675	0.0377	CbGeAlD
Pancuronium—CHRNA2—brain—attention deficit hyperactivity disorder	0.00589	0.0329	CbGeAlD
Pancuronium—BCHE—forebrain—attention deficit hyperactivity disorder	0.00563	0.0314	CbGeAlD
Pancuronium—CHRNB1—brain—attention deficit hyperactivity disorder	0.00548	0.0306	CbGeAlD
Pancuronium—BCHE—cardiovascular system—attention deficit hyperactivity disorder	0.00476	0.0266	CbGeAlD
Pancuronium—CHRM2—nervous system—attention deficit hyperactivity disorder	0.0046	0.0257	CbGeAlD
Pancuronium—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.00452	0.0252	CbGeAlD
Pancuronium—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00443	0.0247	CbGeAlD
Pancuronium—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.00435	0.0243	CbGeAlD
Pancuronium—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00374	0.0209	CbGeAlD
Pancuronium—BCHE—midbrain—attention deficit hyperactivity disorder	0.00372	0.0208	CbGeAlD
Pancuronium—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00361	0.0201	CbGeAlD
Pancuronium—CHRM2—brain—attention deficit hyperactivity disorder	0.00351	0.0196	CbGeAlD
Pancuronium—SLC22A1—brain—attention deficit hyperactivity disorder	0.00345	0.0193	CbGeAlD
Pancuronium—BCHE—nervous system—attention deficit hyperactivity disorder	0.00306	0.0171	CbGeAlD
Pancuronium—BCHE—central nervous system—attention deficit hyperactivity disorder	0.00294	0.0164	CbGeAlD
Pancuronium—BCHE—cerebellum—attention deficit hyperactivity disorder	0.00288	0.0161	CbGeAlD
Pancuronium—CHRM3—brain—attention deficit hyperactivity disorder	0.00286	0.016	CbGeAlD
Pancuronium—BCHE—brain—attention deficit hyperactivity disorder	0.00234	0.013	CbGeAlD
Pancuronium—CHRNA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00135	0.00165	CbGpPWpGaD
Pancuronium—CHRND—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00135	0.00165	CbGpPWpGaD
Pancuronium—CHRM3—Integration of energy metabolism—SNAP25—attention deficit hyperactivity disorder	0.00135	0.00164	CbGpPWpGaD
Pancuronium—CHRND—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00134	0.00164	CbGpPWpGaD
Pancuronium—BCHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.0013	0.00158	CbGpPWpGaD
Pancuronium—CHRNA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00129	0.00157	CbGpPWpGaD
Pancuronium—CHRM3—Integration of energy metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00128	0.00156	CbGpPWpGaD
Pancuronium—CHRM2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00126	0.00154	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00121	0.00147	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00118	0.00144	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00117	0.00142	CbGpPWpGaD
Pancuronium—SLC22A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00116	0.00141	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00116	0.00141	CbGpPWpGaD
Pancuronium—CHRM3—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00116	0.00141	CbGpPWpGaD
Pancuronium—CHRNA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00115	0.0014	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00115	0.0014	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00115	0.0014	CbGpPWpGaD
Pancuronium—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00115	0.0014	CbGpPWpGaD
Pancuronium—CHRNA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00114	0.00139	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00114	0.00139	CbGpPWpGaD
Pancuronium—BCHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00112	0.00136	CbGpPWpGaD
Pancuronium—CHRNA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00109	0.00133	CbGpPWpGaD
Pancuronium—CHRNA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00109	0.00132	CbGpPWpGaD
Pancuronium—SLC22A1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00108	0.00132	CbGpPWpGaD
Pancuronium—BCHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00104	0.00127	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00104	0.00126	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00101	0.00123	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.001	0.00122	CbGpPWpGaD
Pancuronium—SLC22A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000998	0.00122	CbGpPWpGaD
Pancuronium—BCHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000996	0.00121	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000991	0.00121	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000982	0.0012	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000979	0.00119	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000965	0.00118	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000965	0.00118	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000934	0.00114	CbGpPWpGaD
Pancuronium—SLC22A1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00093	0.00113	CbGpPWpGaD
Pancuronium—SLC22A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000928	0.00113	CbGpPWpGaD
Pancuronium—BCHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000926	0.00113	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00092	0.00112	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000913	0.00111	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.000911	0.00111	CbGpPWpGaD
Pancuronium—SLC22A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000889	0.00108	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000871	0.00106	CbGpPWpGaD
Pancuronium—SLC22A1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000865	0.00105	CbGpPWpGaD
Pancuronium—BCHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000856	0.00104	CbGpPWpGaD
Pancuronium—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000856	0.00104	CbGpPWpGaD
Pancuronium—SLC22A1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000829	0.00101	CbGpPWpGaD
Pancuronium—SLC22A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000827	0.00101	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000802	0.000977	CbGpPWpGaD
Pancuronium—BCHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000796	0.00097	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000794	0.000967	CbGpPWpGaD
Pancuronium—BCHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000787	0.000959	CbGpPWpGaD
Pancuronium—BCHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000782	0.000952	CbGpPWpGaD
Pancuronium—SLC22A1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000771	0.000939	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000771	0.000939	CbGpPWpGaD
Pancuronium—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000765	0.000932	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000763	0.000929	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000755	0.00092	CbGpPWpGaD
Pancuronium—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000748	0.000911	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000748	0.000911	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000726	0.000885	CbGpPWpGaD
Pancuronium—SLC22A1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000713	0.000868	CbGpPWpGaD
Pancuronium—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000711	0.000866	CbGpPWpGaD
Pancuronium—BCHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00071	0.000864	CbGpPWpGaD
Pancuronium—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000703	0.000857	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000701	0.000854	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000701	0.000854	CbGpPWpGaD
Pancuronium—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000698	0.000851	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000694	0.000846	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000687	0.000837	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00068	0.000829	CbGpPWpGaD
Pancuronium—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000674	0.00082	CbGpPWpGaD
Pancuronium—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000671	0.000817	CbGpPWpGaD
Pancuronium—SLC22A1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000663	0.000807	CbGpPWpGaD
Pancuronium—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000662	0.000806	CbGpPWpGaD
Pancuronium—SLC22A1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000655	0.000798	CbGpPWpGaD
Pancuronium—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000654	0.000796	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000652	0.000794	CbGpPWpGaD
Pancuronium—SLC22A1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000651	0.000793	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000649	0.000791	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000645	0.000786	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000643	0.000783	CbGpPWpGaD
Pancuronium—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000634	0.000772	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000631	0.000769	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000625	0.000761	CbGpPWpGaD
Pancuronium—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000625	0.000761	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00062	0.000756	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000614	0.000748	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000613	0.000746	CbGpPWpGaD
Pancuronium—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000609	0.000742	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000607	0.000739	CbGpPWpGaD
Pancuronium—BCHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000603	0.000735	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000601	0.000732	CbGpPWpGaD
Pancuronium—BCHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000599	0.00073	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000595	0.000724	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000592	0.000721	CbGpPWpGaD
Pancuronium—SLC22A1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000591	0.00072	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00059	0.000718	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000584	0.000711	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000571	0.000695	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000565	0.000689	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000558	0.00068	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000553	0.000674	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000541	0.000659	CbGpPWpGaD
Pancuronium—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000539	0.000656	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000536	0.000652	CbGpPWpGaD
Pancuronium—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000535	0.000652	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000532	0.000647	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000526	0.000641	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000525	0.000639	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000523	0.000637	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00052	0.000633	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000518	0.000631	CbGpPWpGaD
Pancuronium—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000517	0.00063	CbGpPWpGaD
Pancuronium—SLC22A1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000502	0.000612	CbGpPWpGaD
Pancuronium—SLC22A1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000499	0.000607	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000489	0.000596	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000484	0.00059	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000463	0.000563	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000457	0.000557	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000453	0.000552	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000435	0.00053	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000431	0.000525	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000427	0.00052	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000425	0.000518	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000422	0.000515	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000421	0.000513	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000412	0.000502	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000408	0.000497	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000405	0.000493	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000401	0.000488	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0004	0.000487	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0004	0.000487	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000396	0.000482	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000396	0.000482	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000395	0.000482	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000392	0.000477	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000387	0.000472	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000384	0.000467	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000372	0.000454	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000369	0.000449	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000363	0.000443	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000348	0.000424	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000345	0.00042	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000343	0.000417	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000341	0.000415	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000339	0.000413	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000324	0.000395	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000318	0.000387	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000314	0.000382	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000302	0.000368	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000296	0.00036	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000293	0.000357	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000279	0.00034	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000272	0.000331	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000269	0.000328	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000269	0.000327	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000266	0.000324	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000261	0.000318	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000258	0.000315	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000258	0.000315	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000256	0.000312	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000251	0.000305	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000251	0.000305	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000247	0.000301	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00024	0.000293	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000238	0.00029	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000235	0.000286	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000234	0.000285	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000233	0.000283	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000232	0.000283	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000231	0.000282	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00023	0.000281	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000229	0.000279	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000229	0.000279	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000229	0.000279	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000227	0.000276	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000227	0.000276	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000226	0.000275	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000224	0.000273	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000224	0.000273	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000224	0.000273	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000224	0.000273	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000222	0.000271	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00022	0.000268	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000218	0.000266	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000216	0.000263	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000211	0.000257	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00021	0.000256	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000209	0.000255	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000209	0.000254	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000209	0.000254	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000208	0.000254	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000208	0.000253	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000206	0.000251	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000205	0.00025	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000205	0.00025	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000205	0.00025	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000203	0.000247	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.0002	0.000244	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000193	0.000235	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000193	0.000235	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000191	0.000233	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000191	0.000233	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000191	0.000232	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00019	0.000231	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000189	0.000231	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000179	0.000218	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000176	0.000215	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00017	0.000208	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000167	0.000203	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000159	0.000194	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000159	0.000193	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000157	0.000191	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000154	0.000188	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.000152	0.000185	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000151	0.000184	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000147	0.00018	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000147	0.000179	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000146	0.000178	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000146	0.000178	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000139	0.000169	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000137	0.000167	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000136	0.000165	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000135	0.000164	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000134	0.000163	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000133	0.000161	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000129	0.000157	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000128	0.000155	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000126	0.000154	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000126	0.000153	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000125	0.000152	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000124	0.000151	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000123	0.000149	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000122	0.000148	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000121	0.000148	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00012	0.000146	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000117	0.000142	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000116	0.000141	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000113	0.000138	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000112	0.000136	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.91e-05	9.63e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.83e-05	9.54e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	6.52e-05	7.94e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	5.82e-05	7.09e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	5.42e-05	6.61e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	5.01e-05	6.1e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.19e-05	5.1e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.15e-05	5.05e-05	CbGpPWpGaD
